Obstetrics & Gynecology, Reproductive Endocrinology · New York, NY
NPI
1972666931
Since 2006
Specialty
Obstetrics & Gynecology, Reproductive Endocrinology
Code 207VE0102X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
50 E 77th St
New York, NY, 10075
Phone (212) 639-9122
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$101K
496 prescriptions
Company payments, 2024
$13.35
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Cristina Matera prescribed most often to Medicare patients was Estradiol (Twice Weekly) (Estradiol), with 71 prescriptions and refills. In total Cristina Matera wrote 496 Medicare prescriptions that cost $101K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Estradiol (Twice Weekly) Estradiol | 71 | 156 | 19 | $6,498 |
| Premarin Estrogens, Conjugated | 59 | 152 | 30 | $26K |
| Estradiol Generic | 54 | 128 | 24 | $9,307 |
| Estring Estradiol | 39 | 117 | 14 | $20K |
| Imvexxy Estradiol | 38 | 82 | Under 11 | $19K |
| Progesterone Progesterone, Micronized | 31 | 70 | 11 | $575 |
| Dotti Estradiol | 28 | 55 | Under 11 | $3,538 |
| Minoxidil Generic | 17 | 37 | Under 11 | $186 |
| Fluconazole Generic | 16 | 17 | Under 11 | $200 |
| Clobetasol Propionate Generic | 16 | 16 | 12 | $130 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 16 | 16 | Under 11 | $177 |
| Vivelle-Dot Estradiol | 11 | 29 | Under 11 | $4,709 |
Brand drugs: 224 claims; generic drugs: 272 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Cristina Matera $13.35 ($13.35 in general payments such as food, travel and fees) from 1 company. The largest payer was Millicent US Inc with $13.35.
| Company | Payments | Amount |
|---|---|---|
| Millicent US Inc | 1 | $13.35 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.